| NDC Code: |
0173-0362 |
| Proprietary Name: |
ZANTAC |
| Suffix: |
|
| Non-Proprietary Name: |
ranitidine hydrochloride |
| Dosage Form: |
INJECTION, SOLUTION |
| Method: |
INTRAMUSCULAR; INTRAVENOUS |
| Original Marketing Date: |
01-10-1989 |
| End of Marketing: |
31-08-2014 |
| Category Name: |
NDA |
| Application Number: |
NDA019090 |
| Labeler: |
GLAXOSMITHKLINE LLC |
| Substance Name: |
RANITIDINE HYDROCHLORIDE |
| Active Numerator Strength: |
25 |
| Active Ingredient Unit: |
mg/mL |
| Pharm Classes: |
Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule: |
|
